80 related articles for article (PubMed ID: 17933497)
1. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Sacchetti E; Valsecchi P; Parrinello G;
Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
Yoon HJ; Park KM; Choi WJ; Choi SH; Park JY; Kim JJ; Seok JH
BMC Psychiatry; 2013 Sep; 13():240. PubMed ID: 24074357
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.
Nakajima S; Takeuchi H; Fervaha G; Plitman E; Chung JK; Caravaggio F; Iwata Y; Mihashi Y; Gerretsen P; Remington G; Mulsant B; Graff-Guerrero A
Schizophr Res; 2015 Feb; 161(2-3):429-33. PubMed ID: 25556080
[TBL] [Abstract][Full Text] [Related]
4. Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.
Kjelby E; Jørgensen HA; Kroken RA; Løberg EM; Johnsen E
BMC Psychiatry; 2011 Aug; 11():145. PubMed ID: 21884578
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
Olfson M; Gerhard T; Huang C; Lieberman JA; Bobo WV; Crystal S
Schizophr Bull; 2012 Jun; 38(4):845-53. PubMed ID: 21307041
[TBL] [Abstract][Full Text] [Related]
6. Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).
García-Cabeza I; Gómez JC; Sacristán JA; Edgell E; González de Chavez M
BMC Psychiatry; 2001; 1():7. PubMed ID: 11835695
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
Awad G; Hassan M; Loebel A; Hsu J; Pikalov A; Rajagopalan K
BMC Psychiatry; 2014 Feb; 14():53. PubMed ID: 24559217
[TBL] [Abstract][Full Text] [Related]
8. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.
Vigen CL; Mack WJ; Keefe RS; Sano M; Sultzer DL; Stroup TS; Dagerman KS; Hsiao JK; Lebowitz BD; Lyketsos CG; Tariot PN; Zheng L; Schneider LS
Am J Psychiatry; 2011 Aug; 168(8):831-9. PubMed ID: 21572163
[TBL] [Abstract][Full Text] [Related]
9. Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
Meyer JM; Davis VG; McEvoy JP; Goff DC; Nasrallah HA; Davis SM; Daumit GL; Hsiao J; Swartz MS; Stroup TS; Lieberman JA
Schizophr Res; 2008 Aug; 103(1-3):104-9. PubMed ID: 18534821
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Volavka J; Czobor P; Citrome L; Van Dorn RA
CNS Spectr; 2014 Oct; 19(5):374-81. PubMed ID: 24284234
[TBL] [Abstract][Full Text] [Related]
11. Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial.
Hermes E; Rosenheck R
J Psychopharmacol; 2012 Sep; 26(9):1194-200. PubMed ID: 22516668
[TBL] [Abstract][Full Text] [Related]
12. Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.
Takeuchi H; Suzuki T; Remington G; Bies RR; Abe T; Graff-Guerrero A; Watanabe K; Mimura M; Uchida H
Schizophr Bull; 2013 Sep; 39(5):993-8. PubMed ID: 23821768
[TBL] [Abstract][Full Text] [Related]
13. Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia.
Rosenheck R; Lin H
J Nerv Ment Dis; 2014 Jan; 202(1):18-24. PubMed ID: 24375207
[TBL] [Abstract][Full Text] [Related]
14. Switching elderly patients with dementia from risperidone to quetiapine: a retrospective study.
Madhusoodanan S; Bogunovic O
Am J Alzheimers Dis Other Demen; 2006; 21(3):169-74. PubMed ID: 16869337
[TBL] [Abstract][Full Text] [Related]
15. Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
Yoshida K; Roberts R; Suzuki T; Lebowitz B; Reeves S; Howard R; Abe T; Mimura M; Uchida H
Am J Geriatr Psychiatry; 2017 Jul; 25(7):708-716. PubMed ID: 28215900
[TBL] [Abstract][Full Text] [Related]
16. Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.
Addington DE; Mohamed S; Rosenheck RA; Davis SM; Stroup TS; McEvoy JP; Swartz MS; Lieberman JA
J Clin Psychiatry; 2011 Jan; 72(1):75-80. PubMed ID: 20868641
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.
Feng XZ; Li Z; Li ZY; Wang K; Tan X; Zhao YY; Mi WF; Zhu WL; Bao YP; Lu L; Li SX
Psychiatry Res; 2024 Feb; 332():115637. PubMed ID: 38150810
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial.
Xiu M; Zhao L; Sun Q; Lang X
Curr Neuropharmacol; 2024; 22(8):1406-1413. PubMed ID: 37711125
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia.
Galbally M; Wynter K; Siskind D; Correll CU; Northwood K; Every-Palmer S
CNS Drugs; 2024 Jul; 38(7):559-570. PubMed ID: 38713452
[TBL] [Abstract][Full Text] [Related]
20. The Comparison of Olanzapine and Risperidone Treatment in Male Schizophrenic Patients using Positive and Negative Syndromes Scale (PANSS).
Lestari ET; Effendy E; Amin MM; Loebis B
Open Access Maced J Med Sci; 2018 Apr; 6(4):638-642. PubMed ID: 29731930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
